Graduate Program in Pharmacology, Department of Pharmacology, Center of Biological Sciences, Federal University of Paraná, Curitiba, 88015-420, PR, Brazil.
Purinergic Signal. 2012 Dec;8(4):693-704. doi: 10.1007/s11302-012-9299-2. Epub 2012 Mar 29.
Adenosine and its metabolite, inosine, have been described as molecules that participate in regulation of inflammatory response. The aim of this study was to investigate the effect of adenosine and inosine in a mouse model of carrageenan-induced pleurisy as well as the participation of adenosine receptors in this response. Injection of carrageenan into the pleural cavity induced an acute inflammatory response characterized by leukocyte migration, pleural exudation, and increased release of interleukin-1β and tumor necrosis factor-α in pleural exudates. The treatment with adenosine (0.3-100 mg/kg, i.p.) and inosine (0.1-300 mg/kg, i.p.) 30 min before carrageenan injection reduced significantly all these parameters analyzed. Our results also demonstrated that A(2A) and A(2B) receptors seem to mediate the adenosine and inosine effects observed, since pretreatment with selective antagonists of adenosine A(2A) (ZM241385) and A(2B) (alloxazine) receptors, reverted the inhibitory effects of adenosine and inosine in pleural inflammation. The involvement of A(2) receptors was reinforced with adenosine receptor agonist CGS21680 treatment, since its anti-inflammatory effects were reversed completely and partially with ZM241385 and alloxazine injection, respectively. Moreover, the combined treatment with subeffective dose of adenosine (0.3 mg/kg) and inosine (1.0 mg/kg) induced a synergistic anti-inflammatory effect. Thus, based on these findings, we propose that inosine contributes with adenosine to exert anti-inflammatory effects in pleural inflammation, reinforcing the notion that endogenous nucleosides play an important role in controlling inflammatory diseases. This effect is likely mediated by the activation of adenosine A(2) subtype receptors and inhibition of production or release of pro-inflammatory cytokines.
腺苷及其代谢产物肌苷已被描述为参与炎症反应调节的分子。本研究旨在探讨腺苷和肌苷在卡拉胶诱导的胸膜炎小鼠模型中的作用,以及腺苷受体在这种反应中的参与。向胸膜腔内注射卡拉胶可引起白细胞迁移、胸腔渗出物增加以及胸腔渗出物中白细胞介素-1β和肿瘤坏死因子-α释放增加的急性炎症反应。在卡拉胶注射前 30 分钟给予腺苷(0.3-100mg/kg,腹腔内注射)和肌苷(0.1-300mg/kg,腹腔内注射)治疗可显著降低所有这些参数。我们的结果还表明,A2A 和 A2B 受体似乎介导了观察到的腺苷和肌苷的作用,因为预先给予腺苷 A2A(ZM241385)和 A2B(别嘌呤醇)受体的选择性拮抗剂,可逆转腺苷和肌苷对胸膜炎的抑制作用。通过给予腺苷受体激动剂 CGS21680 进行治疗,进一步证实了 A2 受体的参与,因为其抗炎作用完全和部分被 ZM241385 和别嘌呤醇注射逆转。此外,给予亚效剂量的腺苷(0.3mg/kg)和肌苷(1.0mg/kg)联合治疗可产生协同抗炎作用。因此,基于这些发现,我们提出肌苷与腺苷一起在胸膜炎中发挥抗炎作用,这进一步证明内源性核苷在控制炎症性疾病中起着重要作用。这种作用可能是通过激活腺苷 A2 亚型受体和抑制促炎细胞因子的产生或释放来介导的。